Your browser doesn't support javascript.
Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.
Ghazy, Ramy Mohamed; Abdou, Marwa Shawky; Awaidy, Salah; Sallam, Malik; Elbarazi, Iffat; Youssef, Naglaa; Fiidow, Osman Abubakar; Mehdad, Slimane; Hussein, Mohamed Fakhry; Adam, Mohammed Fathelrahman; Abdullah, Fatimah Saed Alabd; Rebai, Wafa Kammoun; Raad, Etwal Bou; Hussein, Mai; Shehata, Shehata F; Ismail, Ismail Ibrahim; Salam, Arslan Ahmed; Samhouri, Dalia.
  • Ghazy RM; Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.
  • Abdou MS; Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.
  • Awaidy S; Health Affairs, Ministry of Health, Muscat 100, Oman.
  • Sallam M; Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
  • Elbarazi I; Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan.
  • Youssef N; Department of Translational Medicine, Faculty of Medicine, Lund University, 22184 Malmö, Sweden.
  • Fiidow OA; Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, AlAin 15551, United Arab Emirates.
  • Mehdad S; Department of Medical-Surgical Nursing, College of Nursing, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
  • Hussein MF; School of Public Health and Research, Somali National University, Mogadishu P.O. Box 15, Somalia.
  • Adam MF; Physiology and Physiopathology Research Team, Research Centre of Human Pathology Genomics, Faculty of Sciences, Mohammed V University, Rabat BP 8007, Morocco.
  • Abdullah FSA; Occupational Health and Industrial Medicine Department, High Institute of Public Health, Alexandria University, Alexandria 21526, Egypt.
  • Rebai WK; Faculty of Pharmacy, University of Science and Technology, Khartoum P.O. Box 12810, Sudan.
  • Raad EB; Internal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.
  • Hussein M; Institute Pasteur de Tunis, Tunis 2092, Tunisia.
  • Shehata SF; Department of Epidemiology and Population Health, American University of Beirut, Beirut P.O. Box 110236, Lebanon.
  • Ismail II; School of Pharmacy, Lebanese International University, Beirut P.O. Box 146404, Lebanon.
  • Salam AA; Clinical Research Administration, Alexandria Directorate of Health Affairs, Egyptian Ministry of Health and Population, Alexandria 21554, Egypt.
  • Samhouri D; Harvard Medical School, Boston, MA 02115, USA.
Int J Environ Res Public Health ; 19(19)2022 Sep 25.
Article in English | MEDLINE | ID: covidwho-2043749
ABSTRACT
Coronavirus disease (COVID-19) booster doses decrease infection transmission and disease severity. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in low, middle, and high-income countries of the East Mediterranean Region (EMR) and its determinants using the health belief model (HBM). In addition, we aimed to identify the causes of booster dose rejection and the main source of information about vaccination. Using the snowball and convince sampling technique, a bilingual, self-administered, anonymous questionnaire was used to collect the data from 14 EMR countries through different social media platforms. Logistic regression analysis was used to estimate the key determinants that predict vaccination acceptance among respondents. Overall, 2327 participants responded to the questionnaire. In total, 1468 received compulsory doses of vaccination. Of them, 739 (50.3%) received booster doses and 387 (26.4%) were willing to get the COVID-19 vaccine booster doses. Vaccine booster dose acceptance rates in low, middle, and high-income countries were 73.4%, 67.9%, and 83.0%, respectively (p < 0.001). Participants who reported reliance on information about the COVID-19 vaccination from the Ministry of Health websites were more willing to accept booster doses (79.3% vs. 66.6%, p < 0.001). The leading causes behind booster dose rejection were the beliefs that booster doses have no benefit (48.35%) and have severe side effects (25.6%). Determinants of booster dose acceptance were age (odds ratio (OR) = 1.02, 95% confidence interval (CI) 1.01-1.03, p = 0.002), information provided by the Ministry of Health (OR = 3.40, 95% CI 1.79-6.49, p = 0.015), perceived susceptibility to COVID-19 infection (OR = 1.88, 95% CI 1.21-2.93, p = 0.005), perceived severity of COVID-19 (OR = 2.08, 95% CI 137-3.16, p = 0.001), and perceived risk of side effects (OR = 0.25, 95% CI 0.19-0.34, p < 0.001). Booster dose acceptance in EMR is relatively high. Interventions based on HBM may provide useful directions for policymakers to enhance the population's acceptance of booster vaccination.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph191912136

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph191912136